منابع مشابه
Part II In megaloblastic anaemia EDITORIAL
Bock, 0. A. A., Arapakis, G., Witts, L. J., and Richards, W. C. D. (1963a). The serum pepsinogen level with special reference to the histology of the gastric mucosa. Gut, 4, 106-1 11. Richards, W. C. D., and Witts, L. J. (1963b). The relationship between acid secretion after augmented histamine stimulation and the histology of the gastric mucosa. Ibid., 4, 112-114. Coghill, N. F. (1960). The si...
متن کاملBone Marrow Transplantation in Thalassemia (Part 2)
During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...
متن کاملRevised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure, part III.2: treatment of anaemia with iron.
1. Voytovich MH, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmenn A. Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrol Dial Transplant 2005; 20: 413–418 2. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002; 25 [Suppl 1]: 33...
متن کاملThe fluorescence spectra of pterins and their possible use in the elucidation of the antipernicious anaemia factor. Part 2.
The chemical nature of the antipernicious anaemia factor stored in the liver is not yet established. But there is some indication that the argentaffine cells in the epithelium of the stomach and intestine are connected with the elaboration of this material, as they are found in those parts of the mucous membrane which are therapeutically active against pernicious anaemia, and their number is re...
متن کاملbone marrow transplantation in thalassemia (part 2)
during the last two decades conventional therapy has improved the prognosis of thalassemia. however, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. bone marrow transplantation (bmt) can prevent or delay progression of the aforementioned complications. the importance of clinical research...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: South African Medical Journal
سال: 2017
ISSN: 2078-5135
DOI: 10.7196/samj.2017.v107i2.12224